Prevalence of Fluoroquinolone-Resistant <i>Campylobacter</i> Species in Iran: A Systematic Review and Meta-Analysis.

Int J Microbiol · 2020 · PMC7803110 · PMID 33488728

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Fluoroquinolones are selective drugs in the treatment of campylobacteriosis; however, an increasing trend of resistance in Campylobacter species isolated from human and animal origins has been reported in the USA and Canada (19–47%), European countries (17–99%), and Africa and Asia (>80%) [ 5 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.